|

(R)-9bMS Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Mahatinib

Pipeline

Phase 1: 1

Top Sponsors

  • TechnoGenesys, Inc.1

Indications

  • Metastatic Castration-Resistant Prostate Carcinoma1
  • Metastatic Castration-resistant Prostate Cancer (CRPC)1
  • Cancer1

Madison, Wisconsin1 trial

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.